ArticleStatistics in medicine2025
A Sensitivity Analysis Framework Using the Proxy Pattern-Mixture Model for Generalization of Experimental Results.
Article in Statistics in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Generalizing findings from randomized controlled trials (RCTs) to a target population is challenging when unmeasured factors influence both trial participation and outcomes. We propose a novel sensitivity analysis framework to assess the impact of such unmeasured factors on treatment effect estimates called the Proxy Pattern-Mixture Model in the context of RCTs (RCT-PPMM). By leveraging proxy variables derived from baseline covariates, our framework quantifies the potential bias in treatment effect estimates due to nonignorable selection mechanisms. The RCT-PPMM relies on two bounded sensitivity parameters that capture the deviation from sample selection at random and that can be varied systematically to determine how robust trial results are to a departure from ignorable sample selection. The approach only requires summary-level baseline covariate data for the target population (not individual-level data), thus increasing its applicability. Through simulations, we demonstrate that RCT-PPMM can provide information about the potential direction of bias and provide credible intervals that capture the true treatment effect under various nonignorable selection scenarios. We illustrate the use of the method using a yoga intervention RCT for breast cancer survivors, illustrating how conclusions may shift under plausible selection biases. Our approach offers a practical and interpretable tool for evaluating generalizability, particularly when individual-level data on nonparticipants are unavailable, but summary-level covariate data are accessible.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.